Palisade bio (nasdaq: pali) to participate in the 2022 virtual growth conference presented by maxim group and hosted by m-vest

Carlsbad, calif., march 24, 2022 (globe newswire) -- palisade bio, inc. (nasdaq: pali), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (gi) complications, today announced that of palisade bio, will participate in the 2022 virtual growth conference, presented by maxim group llc and hosted by m-vest, taking place on march 28–30, 2022.
PALI Ratings Summary
PALI Quant Ranking